Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa.
Open Access
- 1 November 1993
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 92 (5) , 2540-2545
- https://doi.org/10.1172/jci116863
Abstract
Protease nexin-2/amyloid beta protein precursor (PN-2/A beta PP) is an abundant, secreted platelet protein which is a potent inhibitor of coagulation Factor XIa. We examined other potential anticoagulant activities of PN-2/A beta PP. Purified Kunitz protease inhibitor domain of PN-2/A beta PP and PN-2/A beta PP itself were found to prolong the coagulation time of plasma and pure Factor IXa. The Kunitz protease inhibitor domain also inhibited the ability of Factor IXa to activate Factor X. PN-2/A beta PP inhibited Factor IXa with a Ki of 7.9 to 3.9 x 10(-11) M in the absence and presence of heparin, respectively. When the second-order rate constant of PN-2/A beta PP's inhibition of Factor IXa (2.7 x 10(8) M-1min-1) was compared to that of antithrombin III (3.8 x 10(6) M-1min-1), PN-2/A beta PP was at least a 71-fold more potent inhibitor of Factor IXa than antithrombin III. PN-2/A beta PP formed a complex with Factor IXa as detected by gel filtration and ELISA. The finding that PN-2/A beta PP is a potent inhibitor of Factor IXa could help to explain the spontaneous intracerebral hemorrhages seen in patients with hereditary cerebral hemorrhage with amyloidosis Dutch-type where there is an extensive accumulation of PN-2/A beta PP in their cerebral blood vessels.Keywords
This publication has 27 references indexed in Scilit:
- Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill.Journal of Clinical Investigation, 1985
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984
- Activation of factor IX bound to cultured bovine aortic endothelial cells.Proceedings of the National Academy of Sciences, 1984
- Inactivation of Factor XIa by Plasma Protease InhibitorsJournal of Clinical Investigation, 1982
- The acceleration by polylysine of the activation of factor X by factor IXaThrombosis Research, 1982
- HIGH GENE FREQUENCY OF FACTOR-XI (PTA) DEFICIENCY IN ASHKENAZI JEWS1978
- Haemophilia Treatment in the United Kingdom from 1969 to 1974British Journal of Haematology, 1977
- Inhibition of human factor IXa by human antithrombinJournal of Biological Chemistry, 1975
- Interaction of Plasma Kallikrein with the C1̄ InhibitorThe Journal of Immunology, 1970
- The Mode of Inheritance of PTA Deficiency: Evidence for the Existence of Major PTA Deficiency and Minor PTA DeficiencyBlood, 1961